Policy | July 02, 2025
India exports US$ 4,961 million pharmaceutical during April–May 2025: Pharmexcil
Enhance strategies to drive sustainability, global Reach and digital transformation for a trillion-dollar future
Enhance strategies to drive sustainability, global Reach and digital transformation for a trillion-dollar future
Sun Pharma gets 8 observations from USFDA for Halol facility
The inspection conducted from December 16, 2024 to December 20, 2024 by the Brazil Health Regulatory Agency (ANVISA)
Launched in Thailand, the ASEAN hub, marking an early entry into the fast-growing combination therapy market (DPP-4 and SGLT-2 inhibitor combination) with strong potential for market leadership
Zydus MedTech gets rights to market the innovative Transcatheter Aortic Valve Implantation (TAVI) technology in India, Europe and other select markets
Everolimus TFOS is a kinase inhibitor indicated in adult and paediatric patients aged one year and older with tuberous sclerosis complex for the treatment of subependymal giant cell astrocytoma
Mamilli last held the role of Chief Digital & Technology Officer and Group President for China, Brazil and Precision Animal Health at Zoetis
The successful completion of RRA assessment by the USFDA, would enable company to open up its business in the USA market
Esketamine hydrochloride is a vital drug to be used for treating mental illness and is likely to significantly impact the LATAM market
The first and only immuno-oncology drug approved for the treatment of nasopharyngeal carcinoma
Subscribe To Our Newsletter & Stay Updated
